Thrivent Financial for Lutherans’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-14,962
| Closed | -$2.65M | – | 2335 |
|
|
2020
Q1 | $2.65M | Hold |
14,962
| – | – | 0.01% | 837 |
|
|
2019
Q4 | $2.86M | Buy |
14,962
+64
| +0.4% | +$11.5K | 0.01% | 876 |
|
|
2019
Q3 | $2.51M | Buy |
14,898
+947
| +7% | +$154K | 0.01% | 888 |
|
|
2019
Q2 | $2.34M | Sell |
13,951
-114
| -0.8% | -$15.8K | 0.01% | 915 |
|
|
2019
Q1 | $2.06M | Sell |
14,065
-9,538
| -40% | -$1.38M | 0.01% | 947 |
|
|
2018
Q4 | $3.15M | Buy |
23,603
+9,787
| +71% | +$1.6M | 0.01% | 719 |
|
|
2018
Q3 | $2.63M | Sell |
13,816
-421
| -3% | -$77.3K | 0.01% | 802 |
|
|
2018
Q2 | $2.37M | Buy |
14,237
+358
| +3% | +$57.5K | 0.01% | 838 |
|
|
2018
Q1 | $2.34M | Buy |
13,879
+412
| +3% | +$69.1K | 0.01% | 844 |
|
|
2017
Q4 | $2.2M | Sell |
13,467
-71
| -0.5% | -$12.7K | 0.01% | 877 |
|
|
2017
Q3 | $2.77M | Buy |
13,538
+780
| +6% | +$181K | 0.01% | 770 |
|
|
2017
Q2 | $3.1M | Sell |
12,758
-516,678
| -98% | -$121M | 0.01% | 708 |
|
|
2017
Q1 | $126M | Sell |
529,436
-182,570
| -26% | -$42.5M | 0.55% | 37 |
|
|
2016
Q4 | $150M | Buy |
712,006
+4,653
| +0.7% | +$964K | 0.67% | 27 |
|
|
2016
Q3 | $163M | Sell |
707,353
-45,070
| -6% | -$11M | 0.74% | 19 |
|
|
2016
Q2 | $174M | Buy |
752,423
+17,725
| +2% | +$4.09M | 0.83% | 19 |
|
|
2016
Q1 | $197M | Buy |
734,698
+100,698
| +16% | +$28.8M | 0.95% | 16 |
|
|
2015
Q4 | $198M | Sell |
634,000
-37,826
| -6% | -$11.3M | 0.95% | 13 |
|
|
2015
Q3 | $183M | Buy |
671,826
+93,835
| +16% | +$28.8M | 0.96% | 11 |
|
|
2015
Q2 | $175M | Buy |
577,991
+23,340
| +4% | +$6.96M | 0.97% | 14 |
|
|
2015
Q1 | $165M | Sell |
554,651
-46,364
| -8% | -$13.2M | 0.91% | 17 |
|
|
2014
Q4 | $155M | Buy |
601,015
+84,016
| +16% | +$21M | 0.86% | 20 |
|
|
2014
Q3 | $125M | Buy |
516,999
+428,586
| +485% | +$95.9M | 0.72% | 31 |
|
|
2014
Q2 | $19.7M | Sell |
88,413
-800
| -0.9% | -$166K | 0.11% | 198 |
|
|
2014
Q1 | $18.4M | Buy |
89,213
+110
| +0.1% | +$21.8K | 0.11% | 195 |
|
|
2013
Q4 | $15M | Sell |
89,103
-1,000
| -1% | -$156K | 0.09% | 239 |
|
|
2013
Q3 | $13M | Buy |
90,103
+3,300
| +4% | +$440K | 0.08% | 262 |
|
|
2013
Q2 | $11K | Buy |
+86,803
| New | +$9.83M | 0.07% | 288 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Thrivent Financial for Lutherans's AGN Position: Q2 2020 in Review
Thrivent Financial for Lutherans sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 14,962 shares — an estimated $2.65M sold.
Thrivent Financial for Lutherans first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $198M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Thrivent Financial for Lutherans reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 14,962 Allergan plc shares in Q2 2020, an estimated $2.65M.
- Thrivent Financial for Lutherans first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Thrivent Financial for Lutherans's Allergan plc position peaked at $198M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2020, filed 12 Aug 2020.